Cargando…
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established AS...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402482/ https://www.ncbi.nlm.nih.gov/pubmed/35902419 http://dx.doi.org/10.1007/s00592-022-01942-8 |
_version_ | 1784773187475603456 |
---|---|
author | Orsi, Emanuela Solini, Anna Bonora, Enzo Vitale, Martina Garofolo, Monia Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Laviola, Luigi Morano, Susanna Pugliese, Giuseppe |
author_facet | Orsi, Emanuela Solini, Anna Bonora, Enzo Vitale, Martina Garofolo, Monia Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Laviola, Luigi Morano, Susanna Pugliese, Giuseppe |
author_sort | Orsi, Emanuela |
collection | PubMed |
description | AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established ASCVD, target organ damage (TOD), and/or, in the 2019 classification only, ≥ 3 additional ASCVD risk factors. We assessed risk of all-cause mortality according to the two ESC classifications in the Renal Insufficiency And Cardiovascular Events cohort. METHODS: Participants (n = 15,773) were stratified based on the presence of ASCVD, TOD, and ASCVD risk factors at baseline (2006–2008). Vital status was retrieved in 2015. RESULTS: Less than 1% of participants fell in the moderate-risk category. According to the 2019 classification, ~ 1/3 fell in the high-risk and ~ 2/3 in the very high-risk category, whereas the opposite occurred with the 2021 classification. Mortality risk increased across categories according to both classifications. Among very high-risk patients, mortality was much lower in those with ≥ 3 additional ASCVD risk factors and almost equal in those with TOD and ASCVD ± TOD, using the 2019 classification, whereas it was much higher in those with ASCVD + TOD and, to a lesser extent, TOD only than in those with ASCVD only, using the 2021 classification. CONCLUSIONS: The negligible number of moderate-risk patients suggests that these classifications might overestimate risk of ASCVD death. Downgrading patients with ≥ 3 additional ASCVD risk factors to the high-risk category is consistent with mortality data. Risk of death is very high in the presence of TOD irrespective of established ASCVD. Trial registration: ClinicalTrials.gov, NCT00715481. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01942-8. |
format | Online Article Text |
id | pubmed-9402482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-94024822022-08-26 Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study Orsi, Emanuela Solini, Anna Bonora, Enzo Vitale, Martina Garofolo, Monia Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Laviola, Luigi Morano, Susanna Pugliese, Giuseppe Acta Diabetol Original Article AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established ASCVD, target organ damage (TOD), and/or, in the 2019 classification only, ≥ 3 additional ASCVD risk factors. We assessed risk of all-cause mortality according to the two ESC classifications in the Renal Insufficiency And Cardiovascular Events cohort. METHODS: Participants (n = 15,773) were stratified based on the presence of ASCVD, TOD, and ASCVD risk factors at baseline (2006–2008). Vital status was retrieved in 2015. RESULTS: Less than 1% of participants fell in the moderate-risk category. According to the 2019 classification, ~ 1/3 fell in the high-risk and ~ 2/3 in the very high-risk category, whereas the opposite occurred with the 2021 classification. Mortality risk increased across categories according to both classifications. Among very high-risk patients, mortality was much lower in those with ≥ 3 additional ASCVD risk factors and almost equal in those with TOD and ASCVD ± TOD, using the 2019 classification, whereas it was much higher in those with ASCVD + TOD and, to a lesser extent, TOD only than in those with ASCVD only, using the 2021 classification. CONCLUSIONS: The negligible number of moderate-risk patients suggests that these classifications might overestimate risk of ASCVD death. Downgrading patients with ≥ 3 additional ASCVD risk factors to the high-risk category is consistent with mortality data. Risk of death is very high in the presence of TOD irrespective of established ASCVD. Trial registration: ClinicalTrials.gov, NCT00715481. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01942-8. Springer Milan 2022-07-28 2022 /pmc/articles/PMC9402482/ /pubmed/35902419 http://dx.doi.org/10.1007/s00592-022-01942-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Orsi, Emanuela Solini, Anna Bonora, Enzo Vitale, Martina Garofolo, Monia Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Laviola, Luigi Morano, Susanna Pugliese, Giuseppe Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title | Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title_full | Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title_fullStr | Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title_full_unstemmed | Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title_short | Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study |
title_sort | risk of all-cause mortality according to the european society of cardiology risk categories in individuals with type 2 diabetes: the renal insufficiency and cardiovascular events (riace) italian multicenter study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402482/ https://www.ncbi.nlm.nih.gov/pubmed/35902419 http://dx.doi.org/10.1007/s00592-022-01942-8 |
work_keys_str_mv | AT orsiemanuela riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT solinianna riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT bonoraenzo riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT vitalemartina riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT garofolomonia riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT fondellicecilia riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT trevisanroberto riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT vedovatomonica riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT cavalotfranco riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT laviolaluigi riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT moranosusanna riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT pugliesegiuseppe riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy AT riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy |